Product Name

  • Name

    Riluzole

  • EINECS 605-724-6
  • CAS No. 1744-22-5
  • Density 1.572 g/cm3
  • Solubility DMSO: ≥25 mg/mL
  • Melting Point 116-118 °C
  • Formula C8H5F3N2OS
  • Boiling Point 296.3 °C at 760 mmHg
  • Molecular Weight 234.202
  • Flash Point 133 °C
  • Transport Information UN 2811 6.1/PG 3
  • Appearance white crystalline solid
  • Safety 45
  • Risk Codes 25
  • Molecular Structure Molecular Structure of 1744-22-5 (Riluzole)
  • Hazard Symbols ToxicT,IrritantXi
  • Synonyms Benzothiazole,2-amino-6-(trifluoromethoxy)- (7CI,8CI);6-(Trifluoromethoxy)-1,3-benzothiazol-2-amine;6-(Trifluoromethoxy)-2-aminobenzothiazole;6-Trifluoromethoxybenzothiazol-2-ylamine;PK 26124;RP 54274;Rilutek;
  • PSA 76.38000
  • LogP 3.35830

Synthetic route

4-(trifluoromethoxy)aniline
461-82-5

4-(trifluoromethoxy)aniline

potassium thioacyanate
333-20-0

potassium thioacyanate

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With bromine; acetic acid at 0 - 20℃; for 16h; Inert atmosphere;95%
Stage #1: 4-(trifluoromethoxy)aniline; potassium thioacyanate In acetic acid at 20℃; for 0.333333h;
Stage #2: With bromine In acetic acid at 20℃;
94%
Stage #1: 4-(trifluoromethoxy)aniline; potassium thioacyanate With acetic acid for 0.166667h;
Stage #2: With bromine
86%
4-(trifluoromethoxy)aniline
461-82-5

4-(trifluoromethoxy)aniline

ammonium thiocyanate
1147550-11-5

ammonium thiocyanate

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With benzyltrimethylazanium tribroman-2-uide In acetonitrile at 20℃; for 24h;80%
With benzyltrimethylazanium tribroman-2-uide In acetonitrile at 20℃; for 24h;80%
With benzyltrimethylazanium tribroman-2-uide In acetonitrile80%
4-(trifluoromethoxy)aniline
461-82-5

4-(trifluoromethoxy)aniline

tetrabutylammonium thiocyanate
3674-54-2

tetrabutylammonium thiocyanate

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With benzyltrimethylazanium tribroman-2-uide In dichloromethane at 20℃; for 18h;74%
3-(2-hydroxyethyl)-6-trifluoromethoxy-2-benzothiazoline hydrobromide

3-(2-hydroxyethyl)-6-trifluoromethoxy-2-benzothiazoline hydrobromide

Riluzole
1744-22-5

Riluzole

2-amino-4-nitro-6-trifluoromethoxy-benzothiazole
131395-13-6

2-amino-4-nitro-6-trifluoromethoxy-benzothiazole

2-amino-5-nitro-6-trifluoromethoxy-benzothiazole
131395-12-5

2-amino-5-nitro-6-trifluoromethoxy-benzothiazole

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
In water
2-hydrazinyl-6-(trifluoromethoxy)benzo[d]thiazole
133840-98-9

2-hydrazinyl-6-(trifluoromethoxy)benzo[d]thiazole

Riluzole
1744-22-5

Riluzole

ammonium thiocyanate

ammonium thiocyanate

4-(trifluoromethoxy)aniline
461-82-5

4-(trifluoromethoxy)aniline

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With bromine; acetic acid at 10 - 27℃; for 6.83333h;
C10H8F3N3O2S*ClH
1606922-37-5

C10H8F3N3O2S*ClH

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With blood peptidase
C11H10F3N3O2S*ClH

C11H10F3N3O2S*ClH

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With blood peptidase
2-(methylamino)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]acetamide hydrochloride

2-(methylamino)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]acetamide hydrochloride

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With blood peptidase
C15H16F3N3O4S*ClH

C15H16F3N3O4S*ClH

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride / 1,4-dioxane / 2 h
2: blood peptidase
View Scheme
C16H18F3N3O4S*ClH

C16H18F3N3O4S*ClH

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride / 1,4-dioxane / 2 h
2: blood peptidase
View Scheme
C16H18F3N3O4S*ClH

C16H18F3N3O4S*ClH

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride / 1,4-dioxane / 2 h
2: blood peptidase
View Scheme
N-<4-(trifluoromethoxy)phenyl>thiourea
142229-74-1

N-<4-(trifluoromethoxy)phenyl>thiourea

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
With bromine; acetic acid; lithium bromide at 40℃;
4-(trifluoromethoxy)aniline
461-82-5

4-(trifluoromethoxy)aniline

Riluzole
1744-22-5

Riluzole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trifluoroacetic acid / Isopropyl acetate / 16 h / Reflux
2: acetic acid; lithium bromide; bromine / 40 °C
View Scheme
trifluoromethyl trifluoromethanesulfonate
3582-05-6

trifluoromethyl trifluoromethanesulfonate

Riluzole
1744-22-5

Riluzole

1,3-bis(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)urea

1,3-bis(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)urea

Conditions
ConditionsYield
In acetonitrile at 20℃; for 1h; Sealed tube;96%
Riluzole
1744-22-5

Riluzole

N-allyl isothiocyanate
57-06-7

N-allyl isothiocyanate

1-allyl-3-(6-trifluoromethoxy-1,3-benzothiazol-2-yl)thiourea

1-allyl-3-(6-trifluoromethoxy-1,3-benzothiazol-2-yl)thiourea

Conditions
ConditionsYield
In ethanol for 16h; Reflux;95%
(5R,8R)-9-oxo-5,6,7,9-tetrahydro-8H-5,8-methanobenzo[7]annulene-8-carboxylic acid

(5R,8R)-9-oxo-5,6,7,9-tetrahydro-8H-5,8-methanobenzo[7]annulene-8-carboxylic acid

Riluzole
1744-22-5

Riluzole

(5R,8R)-9-oxo-N-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)-5,6,7,9-tetrahydro-8H-5,8-methanobenzo[7]annulene-8-carboxamide

(5R,8R)-9-oxo-N-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)-5,6,7,9-tetrahydro-8H-5,8-methanobenzo[7]annulene-8-carboxamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 15h;94%
2-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenoxy}acetic acid
763903-09-9

2-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenoxy}acetic acid

Riluzole
1744-22-5

Riluzole

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenoxy}acetamide
1392441-96-1

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenoxy}acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;93%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 24h;80%
Stage #1: Riluzole With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
Stage #2: 2-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenoxy}acetic acid In dichloromethane at 25℃; for 24h;
80%
p-cyanophenyl isocyanate
40465-45-0

p-cyanophenyl isocyanate

Riluzole
1744-22-5

Riluzole

1-(4-cyanophenyl)-3-(6-trifluoromethoxybenzothiazol 2-yl)urea
1343448-00-9

1-(4-cyanophenyl)-3-(6-trifluoromethoxybenzothiazol 2-yl)urea

Conditions
ConditionsYield
In dichloromethane at 20℃; for 5h;93%
methanol
67-56-1

methanol

Riluzole
1744-22-5

Riluzole

N-methyl-6-(trifluoromethoxy)benzo[d]thiazol-2-amine
133840-97-8

N-methyl-6-(trifluoromethoxy)benzo[d]thiazol-2-amine

Conditions
ConditionsYield
With bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; sodium hydroxide at 150℃; for 12h; Inert atmosphere; Schlenk technique; Green chemistry;92%
para-fluorophenyl isocyanate
1195-45-5

para-fluorophenyl isocyanate

Riluzole
1744-22-5

Riluzole

1-(4-fluorophenyl)-3-(6-trifluoromethoxybenzothiazol-2-yl)urea
1343447-98-2

1-(4-fluorophenyl)-3-(6-trifluoromethoxybenzothiazol-2-yl)urea

Conditions
ConditionsYield
In dichloromethane at 20℃; for 5h;91%
Riluzole
1744-22-5

Riluzole

2-hydrazinyl-6-(trifluoromethoxy)benzo[d]thiazole
133840-98-9

2-hydrazinyl-6-(trifluoromethoxy)benzo[d]thiazole

Conditions
ConditionsYield
With hydrazine dihydrochloride; hydrazine hydrate In ethylene glycol at 140℃; for 2h;90%
With hydrazine hydrate; hydrazinium sulfate In water at 130℃; for 4h; Inert atmosphere;75%
With hydrazinium sulfate; hydrazine In ethylene glycol at 140℃; for 2.5h;65%
With hydrazine
With hydrogenchloride; hydrazine hydrate for 5h; Reflux;
Riluzole
1744-22-5

Riluzole

butan-1-ol
71-36-3

butan-1-ol

2-(N-n-butylamine)-6-trifluoromethoxy-benzothiazole
1353280-38-2

2-(N-n-butylamine)-6-trifluoromethoxy-benzothiazole

Conditions
ConditionsYield
With bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; sodium hydroxide at 150℃; for 12h; Inert atmosphere; regioselective reaction;90%
carbon monoxide
201230-82-2

carbon monoxide

N-(2'-iodo-[1,1'-biphenyl]-2-yl)-N-methylacrylamide

N-(2'-iodo-[1,1'-biphenyl]-2-yl)-N-methylacrylamide

Riluzole
1744-22-5

Riluzole

(aR,S)-2-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)acetamide

(aR,S)-2-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)acetamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); C25H23OP; caesium carbonate In toluene at 40℃; under 760.051 Torr; for 10h; Schlenk technique; stereoselective reaction;88%
Riluzole
1744-22-5

Riluzole

benzyl alcohol
100-51-6

benzyl alcohol

N-benzyl-6-(trifluoromethoxy)benzo[d]thiazol-2-amine
1307865-22-0

N-benzyl-6-(trifluoromethoxy)benzo[d]thiazol-2-amine

Conditions
ConditionsYield
With copper(l) chloride; sodium hydroxide In para-xylene at 160℃; for 12h; Inert atmosphere; regioselective reaction;87%
4-Methoxyphenyl isocyanate
5416-93-3

4-Methoxyphenyl isocyanate

Riluzole
1744-22-5

Riluzole

1-(4-methoxyphenyl)-3-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)urea
1343447-99-3

1-(4-methoxyphenyl)-3-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)urea

Conditions
ConditionsYield
In dichloromethane at 20℃; for 5h;84%
mercaptoacetic acid
68-11-1

mercaptoacetic acid

2,3-dichlorobenzylaldehyde
6334-18-5

2,3-dichlorobenzylaldehyde

Riluzole
1744-22-5

Riluzole

3-(6-trifluoromethoxy-benzo[d]thiazol-2-yl)-2-(2,3-dichlorophenyl)thiazolidin-4-one

3-(6-trifluoromethoxy-benzo[d]thiazol-2-yl)-2-(2,3-dichlorophenyl)thiazolidin-4-one

Conditions
ConditionsYield
In ethanol at 100℃; for 0.5h; Sealed tube; Microwave irradiation;84%
methanol
67-56-1

methanol

6-Chloro-4-oxo-4H-chromene-3-carbaldehyde
42248-31-7

6-Chloro-4-oxo-4H-chromene-3-carbaldehyde

Riluzole
1744-22-5

Riluzole

C19H12ClF3N2O4S

C19H12ClF3N2O4S

Conditions
ConditionsYield
at 30 - 40℃; for 10h; stereoselective reaction;82%
(E)-2-(2-methoxy-5-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)phenoxy)acetic acid
1357099-42-3

(E)-2-(2-methoxy-5-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)phenoxy)acetic acid

Riluzole
1744-22-5

Riluzole

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxy}acetamide
1379509-97-3

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxy}acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;81%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 24h;80%
Stage #1: Riluzole With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
Stage #2: (E)-2-(2-methoxy-5-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)phenoxy)acetic acid In dichloromethane at 25℃; for 24h;
80%
2,6-difluorophenyl isocyanate

2,6-difluorophenyl isocyanate

Riluzole
1744-22-5

Riluzole

1-(2,6-difluorophenyl)-3-(6-trifluoromethoxybenzothiazol-2-yl)urea
1343448-03-2

1-(2,6-difluorophenyl)-3-(6-trifluoromethoxybenzothiazol-2-yl)urea

Conditions
ConditionsYield
In dichloromethane at 20℃; for 5h;81%
2-{5-[1-acetyl-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetic acid
1392443-96-7

2-{5-[1-acetyl-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetic acid

Riluzole
1744-22-5

Riluzole

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{5-[1-acetyl-3-(3,4,5-trimethoxy phenyl)-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetamide
1392442-07-7

N1-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)-2-{5-[1-acetyl-3-(3,4,5-trimethoxy phenyl)-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 24h;80%
Stage #1: Riluzole With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
Stage #2: 2-{5-[1-acetyl-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-5-pyrazolyl]-2-methoxyphenoxy}acetic acid In dichloromethane at 25℃; for 24h;
80%
Hexafluoroacetone
684-16-2

Hexafluoroacetone

Riluzole
1744-22-5

Riluzole

N-(2,2,2-trifluoro-1-trifluoromethylethylidene)-6-(trifluoromethoxy)benzothiazol-2-ylamine

N-(2,2,2-trifluoro-1-trifluoromethylethylidene)-6-(trifluoromethoxy)benzothiazol-2-ylamine

Conditions
ConditionsYield
Stage #1: Hexafluoroacetone; Riluzole With pyridine In benzene at 20℃; for 0.5h;
Stage #2: With thionyl chloride In benzene for 1h;
79%
methyl 3,3,3-trifluoropyruvate
13089-11-7

methyl 3,3,3-trifluoropyruvate

Riluzole
1744-22-5

Riluzole

methyl 3,3,3-trifluoro-2-(6-(trifluoromethoxy)benzothiazol-2-ylimino)propionate

methyl 3,3,3-trifluoro-2-(6-(trifluoromethoxy)benzothiazol-2-ylimino)propionate

Conditions
ConditionsYield
Stage #1: methyl 3,3,3-trifluoropyruvate; Riluzole With pyridine In benzene at 20℃; for 0.5h;
Stage #2: With thionyl chloride In benzene for 1h;
78%
methyl hydrogen succinate
3878-55-5

methyl hydrogen succinate

Riluzole
1744-22-5

Riluzole

N-(6-trifluoromethoxy-benzothiazol-2-yl)-succinamic acid methyl ester
1394929-73-7

N-(6-trifluoromethoxy-benzothiazol-2-yl)-succinamic acid methyl ester

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 96h;77%
Riluzole
1744-22-5

Riluzole

2-amino-4-bromo-6-trifluoromethoxy-benzothiazole hydrobromide
144864-70-0

2-amino-4-bromo-6-trifluoromethoxy-benzothiazole hydrobromide

Conditions
ConditionsYield
With bromine In acetic acid at 50℃; for 12h;76%
2-hydroxy-5-t-butylisophthalaldehyde
84501-28-0

2-hydroxy-5-t-butylisophthalaldehyde

Riluzole
1744-22-5

Riluzole

C20H17F3N2O3S

C20H17F3N2O3S

Conditions
ConditionsYield
In ethanol at 20℃;75%
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

Riluzole
1744-22-5

Riluzole

N-[6-(trifluoromethoxy)benzo[d]thiazol-2-yl]methanesulfonamide

N-[6-(trifluoromethoxy)benzo[d]thiazol-2-yl]methanesulfonamide

Conditions
ConditionsYield
With triethylamine In benzene for 2h;75%
Riluzole
1744-22-5

Riluzole

propoxycarbonyl chloride
109-61-5

propoxycarbonyl chloride

(6-trifluoromethoxy-benzothiazol-2-yl)-carbamic acid propyl ester
1394929-66-8

(6-trifluoromethoxy-benzothiazol-2-yl)-carbamic acid propyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 24h;74%
cycloheptanecarbonyl chloride
6557-86-4

cycloheptanecarbonyl chloride

Riluzole
1744-22-5

Riluzole

N-[6-(trifluoromethoxy)benzothiazol-2-yl]cycloheptanecarboxamide

N-[6-(trifluoromethoxy)benzothiazol-2-yl]cycloheptanecarboxamide

Conditions
ConditionsYield
In dichloromethane at 20℃;73%
In dichloromethane at 20℃;
2,6-dichlorobenzaldehyde
83-38-5

2,6-dichlorobenzaldehyde

mercaptoacetic acid
68-11-1

mercaptoacetic acid

Riluzole
1744-22-5

Riluzole

3-(6-trifluoromethoxy-benzo[d]thiazol-2-yl)-2-(2,6-dichlorophenyl)thiazolidin-4-one

3-(6-trifluoromethoxy-benzo[d]thiazol-2-yl)-2-(2,6-dichlorophenyl)thiazolidin-4-one

Conditions
ConditionsYield
In ethanol at 100℃; for 0.5h; Sealed tube; Microwave irradiation;73%
n-hexyl chloroformate
6092-54-2

n-hexyl chloroformate

Riluzole
1744-22-5

Riluzole

(6-trifluoromethoxy-benzothiazol-2-yl)-carbamic acid hexyl ester

(6-trifluoromethoxy-benzothiazol-2-yl)-carbamic acid hexyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 24h;72%

Riluzole Specification

The Riluzole is an organic compound with the formula C8H5F3N2OS. The IUPAC name of this chemical is 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine. With the CAS registry number 1744-22-5, it is also named as 2-Amino-6-trifluoromethoxybenzothiazole. The product's categories are Neuroprotective; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; GABA/Glycine Receptor; Glutamate. Besides, it may have clinical use in mood and anxiety disorders. It has been shown to have antidepressant properties in the treatment of refractory depression and as an anxiolytic in obsessive-compulsive disorder and in GAD.

Physical properties about Riluzole are: (1)ACD/LogP: 2.84; (2)ACD/LogD (pH 5.5): 2.84; (3)ACD/LogD (pH 7.4): 2.84; (4)ACD/BCF (pH 5.5): 84.23; (5)ACD/BCF (pH 7.4): 85.18; (6)ACD/KOC (pH 5.5): 828.83; (7)ACD/KOC (pH 7.4): 838.14; (8)#H bond acceptors: 3; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 1; (11)Polar Surface Area: 53.6 Å2; (12)Index of Refraction: 1.614; (13)Molar Refractivity: 51.94 cm3; (14)Molar Volume: 148.9 cm3; (15)Polarizability: 20.59×10-24cm3; (16)Surface Tension: 49.2 dyne/cm; (17)Density: 1.572 g/cm3; (18)Flash Point: 133 °C; (19)Enthalpy of Vaporization: 53.6 kJ/mol; (20)Boiling Point: 296.3 °C at 760 mmHg; (21)Vapour Pressure: 0.00145 mmHg at 25°C.

Preparation: this chemical can be prepared by 4-trifluoromethoxy aniline and NH4CNS. This reaction will need reagent Acetic acid and bromine. The yield is about 75%.



Uses of Riluzole: it can be used to produce 2-hydrazino-6-trifluoromethoxy-benzothiazole at temperature of 140 °C. It will need reagent hydrazine hydrate, hydrazine dihydrochloride and solvent ethane-1,2-diol with reaction time of 2 hours. The yield is about 90%.

When you are using this chemical, please be cautious about it as the following:
It is toxic if swallowed. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).

You can still convert the following datas into molecular structure:
(1)SMILES: FC(F)(F)Oc1ccc2nc(sc2c1)N
(2)InChI: InChI=1/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
(3)InChIKey: FTALBRSUTCGOEG-UHFFFAOYAB
(4)Std. InChI: InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
(5)Std. InChIKey: FTALBRSUTCGOEG-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 46mg/kg (46mg/kg)   European Patent Application. Vol. #50551,
mouse LD50 intravenous 34500ug/kg (34.5mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ATAXIA
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 1973, 1999.
mouse LD50 oral 67mg/kg (67mg/kg)   European Patent Application. Vol. #50551,
rat LD50 intravenous 22mg/kg (22mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: ATAXIA
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 1973, 1999.
rat LD50 oral 45mg/kg (45mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 1973, 1999.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View